|
PANX1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.150200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.419900E-03 |
| Normal-vs-Stage2 |
7.566000E-01 |
| Normal-vs-Stage3 |
4.407400E-01 |
| Normal-vs-Stage4 |
5.042000E-01 |
| Stage1-vs-Stage2 |
4.360800E-01 |
| Stage1-vs-Stage3 |
7.313500E-02 |
| Stage1-vs-Stage4 |
2.079600E-01 |
| Stage2-vs-Stage3 |
4.373400E-01 |
| Stage2-vs-Stage4 |
4.134600E-01 |
| Stage3-vs-Stage4 |
8.521800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.772200E-02 |
| Normal-vs-AfricanAmerican |
2.121600E-01 |
| Normal-vs-Asian |
4.862000E-01 |
| Caucasian-vs-AfricanAmerican |
9.445800E-01 |
| Caucasian-vs-Asian |
8.758800E-01 |
| AfricanAmerican-vs-Asian |
8.736400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.167920E-04 |
| Normal-vs-Female |
1.053780E-01 |
| Male-vs-Female |
1.388500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.880600E-01 |
| Normal-vs-Extreme_Weight |
2.803400E-04 |
| Normal-vs-Obese |
7.751200E-01 |
| Normal-vs-Extreme_Obese |
2.504200E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.596100E-02 |
| Normal_Weight-vs-Obese |
8.316800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.552300E-02 |
| Extreme_Weight-vs-Obese |
2.232300E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.323600E-01 |
| Obese-vs-Extreme_Obese |
3.708000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.430830E-01 |
| Normal-vs-Age(41-60Yrs) |
3.566600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.181000E-04 |
| Normal-vs-Age(81-100Yrs) |
6.394400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.053570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.277600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.660000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.095400E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.083200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.150400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.28099999999287E-05 |
| Normal-VS-Type2 PRCC |
8.484000E-02 |
| Normal-VS-KIRP CIMP |
3.957700E-03 |
| Normal-VS-Unclassified PRCC |
7.710600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.515850E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.536500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.023900E-03 |
| Type2 PRCC-VS-KIRP CIMP |
2.576400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.826000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.797600E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.379900E-02 |
| Normal-vs-N1 |
1.084420E-01 |
| Normal-vs-N2 |
5.252800E-01 |
| N0-vs-N1 |
2.263900E-02 |
| N0-vs-N2 |
4.052400E-01 |
| N1-vs-N2 |
7.853800E-01 |
|
|
